Cardiac Fibrosis: New Treatments in Cardiovascular Medicine
Cardiac fibrosis is believed to be the final pathway leading to heart failure, which is an extremely common syndrome in the U.S. Much of the pathophysiology of cardiac fibrosis is known. Many drug treatments have been studied and seem promising, but data in humans are both limited and mixed. Although more studies must be conducted to evaluate the safety and efficacy of possible treatments for cardiac fibrosis, there is great hope for the future.
Conclusion
Cardiac fibrosis is believed to be the final pathway leading to heart failure, which is an extremely common syndrome in the U.S. Much of the pathophysiology of cardiac fibrosis is known. Many drug treatments have been studied and seem promising, but data in humans are both limited and mixed. Although more studies must be conducted to evaluate the safety and efficacy of possible treatments for cardiac fibrosis, there is great hope for the future.
SHARE
